Skip to content

Ticker

ARCH:TSXV ACHFF:OTCQB
Arch Biopartners
Arch Biopartners
  • About usOur story, our approach
  • Our ScienceLead drugs & published data
    • Organ Inflammation
      • LSALT Peptide
      • Cilastatin
    • Journal Publications
      • Recent Publications
      • Treatments for Inflammation
  • Investor HubFundamentals, reports & filings
    • Fundamentals
      • Press Releases
      • Investor Information
      • Stock Performance
      • Corporate Presentation
    • Reports and Filings
      • Management Discussion and Analysis
      • Annual and Quarterly Financial Statements
      • Proxies and Management Information Circulars
      • Material Change Documents
      • Other SEDAR Filings
  • Our TeamScience leaders & management team
    • Science Teams
      • LSALT Peptide Scientists
      • Treatments for Inflammation Scientists
    • Management & Directors
      • Executive Team
      • Board of Directors and Advisors
  • Contact Us
Arch Biopartners
  • About usOur story, our approach
  • Our ScienceLead drugs & published data
    • Organ Inflammation
      • LSALT Peptide
      • Cilastatin
    • Journal Publications
      • Recent Publications
      • Treatments for Inflammation
  • Investor HubFundamentals, reports & filings
    • Fundamentals
      • Press Releases
      • Investor Information
      • Stock Performance
      • Corporate Presentation
    • Reports and Filings
      • Management Discussion and Analysis
      • Annual and Quarterly Financial Statements
      • Proxies and Management Information Circulars
      • Material Change Documents
      • Other SEDAR Filings
  • Our TeamScience leaders & management team
    • Science Teams
      • LSALT Peptide Scientists
      • Treatments for Inflammation Scientists
    • Management & Directors
      • Executive Team
      • Board of Directors and Advisors
  • Contact Us

Media

  Home

Metablok – Webinar August 2020

Videos & Media
Contact Arch Biopartners
Stay connected!

Contact Arch Biopartners

Stay connected to receive investor news and email alerts!

Quick Links

Home About Us Our Science Our Team Investor Hub Contact Us
Legal
Terms of Use Privacy Policy Cookie Policy Legal Notices

Connect

+1 647 428 7031

Mailing Address

545 King St W.
Toronto, Ontario
Canada M5V 1M1

© 2025 Arch Biopartners

  • About usOur story, our approach
  • Our ScienceLead drugs & published data
    • Organ Inflammation
      • LSALT Peptide
      • Cilastatin
    • Journal Publications
      • Recent Publications
      • Treatments for Inflammation
  • Investor HubFundamentals, reports & filings
    • Fundamentals
      • Press Releases
      • Investor Information
      • Stock Performance
      • Corporate Presentation
    • Reports and Filings
      • Management Discussion and Analysis
      • Annual and Quarterly Financial Statements
      • Proxies and Management Information Circulars
      • Material Change Documents
      • Other SEDAR Filings
  • Our TeamScience leaders & management team
    • Science Teams
      • LSALT Peptide Scientists
      • Treatments for Inflammation Scientists
    • Management & Directors
      • Executive Team
      • Board of Directors and Advisors
  • Contact Us